The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis

por Salmon, Kristiana, Ross, Jay P., Bertone, Vanessa, Gobbo, Maria, Anoja, Nancy, Karamchandani, Jason, Dion, Patrick A., Rouleau, Guy A., Genge, Angela
Publicado 2022

The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis

por Salmon, Kristiana, Kiernan, Matthew C., Kim, Seung H., Andersen, Peter M., Chio, Adriano, van den Berg, Leonard H., Van Damme, Philip, Al-Chalabi, Ammar, Lillo, Patricia, Andrews, Jinsy A., Genge, Angela
Publicado 2022

Predictive genetic testing for Motor neuron disease: time for a guideline?

por McNeill, Alisdair, Amador, Maria-del-Mar, Bekker, Hilary, Clarke, Angus, Crook, Ashley, Cummings, Cathy, McEwen, Alison, McDermott, Christopher, Quarrell, Oliver, Renieri, Alessandra, Roggenbuck, Jennifer, Salmon, Kristiana, Volk, Alexander, Weishaupt, Jochen
Publicado 2022